Isamu Okamoto

Scopus著者プロファイル

ウェブサイトhttps://hyoka.ofc.kyushu-u.ac.jp/html/100019066_ja.html

h-index

年別の研究成果

404 学術誌
16 総説
14 レター
4 コメント/討論
その他
- 1 編集
- 1 簡易調査

4 件

フィルター

2023
Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1 (International Journal of Clinical Oncology, (2023), 28, 10, (1354-1368), 10.1007/s10147-023-02390-2)
Nishio, M., Ohe, Y., Ikeda, S., Yokoyama, T., Hayashi, H., Fukuhara, T., Sato, Y., Tanaka, H., Hotta, K., Sugawara, S., Daga, H., Okamoto, I., Kasahara, K., Naito, T., Li, L., Gupta, R. G., Bushong, J. & Mizutani, H., 10月 2023, In: International Journal of Clinical Oncology. 28, 10, p. 1369-1370 2 p.
研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

Open Access
2018

Metastatic lung adenocarcinoma mimicking meningioma
Yanagihara, T., Seki, N., Akio, H., Arimura, K., Suzuki, S. & Okamoto, I., 2018, In: Internal Medicine. 57, 7, p. 1057-1058 2 p.
研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

Open Access
2017
Erratum: CNS response to osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFR-TKI sensitising mutation (EGFRm)-positive advanced non-small cell lung cancer (NSCLC): Data from the FLAURA study (Annals of Oncology (2017) 28(S10) (x183), (S0923753419565462), (10.1093/annonc/mdx729))
Vansteenkiste, J., Reungwetwattana, T., Nakagawa, K., Cho, B. C., Dols, M. A. C., Cho, E. K., Bertolini, A., Bohnet, S., Zhou, C., Lee, K. H., Nogami, N., Okamoto, I., Leighl, N., Hodge, R., McKeown, A., Brown, A. P., Rukazenkov, Y. & Ramalingam, S., 11月 2017, In: Annals of Oncology. 28, p. x196
研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読
11 被引用数 (Scopus)
2013

Erratum: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer (Investigational New Drugs (DOI 10.1007/s10637-013-9941-z))
Okamoto, I., Aoe, K., Kato, T., Hosomi, Y., Yokoyama, A., Imamura, F., Kiura, K., Hirashima, T., Nishio, M., Nogami, N., Okamoto, H., Saka, H., Yamamoto, N., Yoshizuka, N., Sekiguchi, R., Kiyosawa, K., Nakagawa, K. & Tamura, T., 10月 2013, In: Investigational New Drugs. 31, 5, p. 1395-1396 2 p.
研究成果: ジャーナルへの寄稿 › コメント/討論 › 査読

1 被引用数 (Scopus)

岡本 勇

研究成果

検索結果

Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1 (International Journal of Clinical Oncology, (2023), 28, 10, (1354-1368), 10.1007/s10147-023-02390-2)

Metastatic lung adenocarcinoma mimicking meningioma

Erratum: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer (Investigational New Drugs (DOI 10.1007/s10637-013-9941-z))

岡本勇